Pharmacogenomic identification of novel markers of response to chemotherapy in colorectal cancer

Pharmacogenomic identification of novel markers of response to chemotherapy in colorectal cancer

Bibliographic Details
Main Author:	McLean, Estelle Grace
Published:	Queen's University Belfast 2006
Subjects:	616.994347061
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.437479

Similar Items

Pharmacogenomic identification and analysis of determinants of response to chemotherapy in colorectal cancer
by: McCulla, Andrea Anna Louise
Published: (2006)

Identification of predictive markers of response to chemotherapy used in the treatment of human gastrointestinal cancers
by: Aroori, S.
Published: (2005)

The role of Fas in chemotherapy-induced colorectal cancer cell death
by: McDermott, Ultan
Published: (2005)

The role of c-FLIP in mediating resistance to chemotherapy in colorectal cancer
by: Wilson, T. R.
Published: (2005)

In vitro characterisation of novel drugs for colorectal cancer
by: Mukherjee, Abhik
Published: (2004)

Integrated individualised treatment of colorectal cancer
by: Whitehouse, Pauline Amanda
Published: (2005)

Immunotherapy of colorectal cancer using bispecific antibodies
by: Safranek, Peter Michael
Published: (2003)

Angiogenesis in colorectal tumours : a therapeutic target?
by: Johnson, A. S.
Published: (2008)

Evaluation of plant extracts for anticancer potential in in vitro assays using colon cancer cell-lines
by: Borkowski, Tomasz
Published: (2009)

NMR investigation in preparation for studies of encapsulated nucleic acids
by: Namaganda, Flavia
Published: (2005)

Identification of predictive markers of response to chemotherapy in advanced colorectal cancer
by: Coyle, V.
Published: (2010)

The role of chronic inflammation in the pathogenesis of sporadic colorectal cancer
by: McLean, Mairi Hall
Published: (2008)

Colorectal cancer : predictive factors for response to chemotherapy
by: Adlard, Julian Weldon
Published: (2004)

A proteomic approach to identifying novel determinants of tumour response to chemotherapy in colorectal cancer
by: Wilson, P. M. D.
Published: (2008)

A novel approach to enhancing the effectiveness of chemotherapy : combining curcumin with FOLFOX chemotherapy for metastatic colorectal cancer
by: Irving, Glen Robert Bell
Published: (2014)

The identification of novel colorectal cancer susceptibility loci
by: Papaemmanuil, Elli
Published: (2009)

Novel pharmacogenomic markers of irinotecan-induced severe toxicity in metastatic colorectal cancer patients
by: Chen, Siwen Sylvialin
Published: (2015)

Identification and characterisation of myofibroblast markers in human colon and colorectal cancer microenvironment
by: Hsia, Lin-Ting
Published: (2015)

The effects of chemotherapy agents on hypoxia in colorectal cancer
by: Siddiky, Abul Hassan
Published: (2015)

Establishing a genotoxic predictive test of toxicities and response to irinotecan chemotherapy in metastatic colorectal cancer
by: Wood, Joanna Peta
Published: (2012)

Functional studies of novel alpha helical peptides
by: McLean, Denise
Published: (2013)

Pharmacogenomics of colorectal cancer in the Taiwanese population
by: Chi-Fang Chen, et al.
Published: (2007)

The role of ADAM 17 in regulating resistance to Chemotherapy Treatment in Colorectal Cancer
by: Doherty, J. E.
Published: (2010)

Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy
by: Zeina N. Al-Mahayri, et al.
Published: (2020-04-01)

FDG-positron emission tomography (PET) as an indicator of response to chemotherapy : a study of patients with upper gastrointestinal cancer and metastic colorectal liver cancer
by: Couper, Graeme
Published: (2004)

A novel method to quantify gamma H2AX foci in circulating tumour cells in patients receiving chemotherapy for colorectal cancer
by: Saggese, Matilde
Published: (2018)

Molecular markers of resistance to chemotherapy in ovarian cancer : statistical issues and study design
by: Hall, Jacqueline A.
Published: (2005)

Regulation of stem cell marker LGR5 by hypoxia in colorectal cancer
by: Emery, Elizabeth Dorothy
Published: (2015)

Defining the role of microRNA-122 in the early detection of chemotherapy-induced hepatotoxicity in the neo-adjuvant treatment of advanced colorectal cancer
by: McWhirter, Derek
Published: (2014)

Pharmacogenomics of non-steroidal antiinflammatory drug-induced gastrointestinal complications
by: Esume, C. O.
Published: (2016)

Identification of tumour-specific T-cells in colorectal cancer patients
by: Robinson, Jonathan Matthew
Published: (2006)

Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments
by: Bruera G, et al.
Published: (2020-11-01)

Pharmacogenomics DNA Biomarkers in Colorectal Cancer: Current Update
by: Nurul-Syakima Ab Mutalib, et al.
Published: (2017-10-01)

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
by: Alessia Bignucolo, et al.
Published: (2017-07-01)

Telomerase : a tumor marker in the peripheral blood of colorectal cancer patients
by: Khair, Ghaith
Published: (2008)

Metabolic profiling analysis of pharmacodynamic responses to chemotherapy in cancer
by: Beech, Adam
Published: (2016)

Pharmacogenomics of chemotherapy induced cognitive dysfunction
by: AlEjielat, Rowan Fahad Ibrahim
Published: (2013)

Identification and validation of new biomarkers for the diagnosis and management of colorectal cancer
by: Pawa, Nikhil
Published: (2015)

Identification of Novel Markers for Prostatic Basal Epithelial Cells and Investigation of their expression and Potential Role in Prostate Cancers
by: Knight, Jennifer Francesca
Published: (2008)

The role of BRCA1 as a marker of clinical outcome following chemotherapy in sporadic ovarian cancer
by: Carser, J. C.
Published: (2010)